[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Retreat Tuesday Afternoon",
    "summary": "Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index shedding 0.5% and the",
    "url": "https://finnhub.io/api/news?id=f005ba03e0e942a4b15e408be475a4ca0b43422d2dca817ce61eb44892b25fa8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761673519,
      "headline": "Sector Update: Health Care Stocks Retreat Tuesday Afternoon",
      "id": 137242484,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index shedding 0.5% and the",
      "url": "https://finnhub.io/api/news?id=f005ba03e0e942a4b15e408be475a4ca0b43422d2dca817ce61eb44892b25fa8"
    }
  },
  {
    "ts": null,
    "headline": "DexCom Shares Fall After Hunterbrook Report on Incidents Related to G7 Glucose Monitor",
    "summary": "DexCom (DXCM) shares were down over 2% in recent Tuesday trading after Hunterbrook issued a report a",
    "url": "https://finnhub.io/api/news?id=25051a7e52e53a3f72e5f4d50a43c064cd7b2008d533186ea3dc0e0357485999",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761666381,
      "headline": "DexCom Shares Fall After Hunterbrook Report on Incidents Related to G7 Glucose Monitor",
      "id": 137242485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DexCom (DXCM) shares were down over 2% in recent Tuesday trading after Hunterbrook issued a report a",
      "url": "https://finnhub.io/api/news?id=25051a7e52e53a3f72e5f4d50a43c064cd7b2008d533186ea3dc0e0357485999"
    }
  },
  {
    "ts": null,
    "headline": "Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?",
    "summary": "DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.",
    "url": "https://finnhub.io/api/news?id=f1671285d6c8f14007909af8e37e3f3893cf929b366b3ba8951eb714cdfffe27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761662160,
      "headline": "Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption?",
      "id": 137242486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes markets.",
      "url": "https://finnhub.io/api/news?id=f1671285d6c8f14007909af8e37e3f3893cf929b366b3ba8951eb714cdfffe27"
    }
  },
  {
    "ts": null,
    "headline": "ViCentra Strengthens Leadership Team to Accelerate Growth",
    "summary": "ViCentra, a European medical device company redefining insulin delivery for people with diabetes with the Kaleido insulin patch pump system, today announced two strategic senior leadership appointments following the company's recent $85 million Series D financing. Karen Baxter, former Vice President & General Manager at Dexcom, joins as Senior Vice President of Sales, Europe, and Jay Little, a long-time commercialization and market access executive at Medtronic Diabetes, takes on the newly creat",
    "url": "https://finnhub.io/api/news?id=8b2e46a639b92ae624592314c9388081bfe001d7774ba7bbc43967c5346cc110",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761640200,
      "headline": "ViCentra Strengthens Leadership Team to Accelerate Growth",
      "id": 137235825,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DXCM",
      "source": "Yahoo",
      "summary": "ViCentra, a European medical device company redefining insulin delivery for people with diabetes with the Kaleido insulin patch pump system, today announced two strategic senior leadership appointments following the company's recent $85 million Series D financing. Karen Baxter, former Vice President & General Manager at Dexcom, joins as Senior Vice President of Sales, Europe, and Jay Little, a long-time commercialization and market access executive at Medtronic Diabetes, takes on the newly creat",
      "url": "https://finnhub.io/api/news?id=8b2e46a639b92ae624592314c9388081bfe001d7774ba7bbc43967c5346cc110"
    }
  }
]